Mijian Raises ￥10M in Pre-A+ Round of Financing

According to VCBeat, Mijian, which focuses on rehabilitation management of cancer patients, has recently raised more than 10 million yuan in the Pre-A+ round of financing, led by Xinrui Jiying. Mijian also obtained a Pre-A round of financing from Tisiwi Venture Capital. The funds raised will be used for the writing and delivery of the popular science content, R&D of its service, and market expansion.

The Mijian APP was officially launched in September 2015, focusing on rehabilitation management of people with severe diseases, especially cancer. Starting from the service for patients into the field of tumor rehabilitation, Mijian has hired a lot of professional medical editors to write popular science content and build the patient community online. After 5 years of development, the APP has gathered more than 1 million cancer patients, making it one of the most active patient platforms with the most cancer patients in China.

In the past two years, Mijian has gradually evolved into a "data-driven rehabilitation management platform for cancer patients", from a superficial information link to a provider of personalized rehabilitation management services throughout the course of the disease connecting various high-quality medical resources.

According to the founder Liu Wengui, the future direction of Mijian is to build a "cancer rehabilitation management system" combining online and offline sources and digitization in the whole course of disease based on the popular science of cancers and medical resources.

Meijian not only pays attention to the physical rehabilitation of patients, but also explores in the psychological rehabilitation, dietary nutrition, sports rehabilitation, and social adaptation of cancer patients jointly with famous experts in China.

Tisiwi Venture Capital was founded in October 2010 in Hangzhou, China. The company invests hundreds of millions of yuan every year, mainly in consumption upgrading, new retail, Industrial Internet, artificial intelligence, deep tech, and other fields.